Market revenue in 2021 | USD 18.1 million |
Market revenue in 2030 | USD 159.3 million |
Growth rate | 27.3% (CAGR from 2021 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.2% in 2021. Horizon Databook has segmented the Mexico ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico is an attractive destination for outsourcing clinical trials as cost plays a major factor. Moreover, proximity to the U.S. and availability of investigators in urban areas help in cost-cutting. As the people in the country cannot afford treatment of chronic diseases, they usually prefer participating in such trials.
Hence, availability of diverse patient pool is one of the factors driving the market. These factors are also supporting adoption of AI-based clinical trial solutions by pharmaceutical companies and others in the country.
In addition, Mexico is also one of the preferred countries in Latin America due to cost saving and speed with which the trials are performed. Increasing number of trials outsourced to this country has led to many regulatory changes, boosting market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into Mexico ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account